Prostatype Genomics Past Earnings Performance
Past criteria checks 0/6
Prostatype Genomics's earnings have been declining at an average annual rate of -35.7%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 19% per year.
Key information
-35.7%
Earnings growth rate
12.3%
EPS growth rate
| Biotechs Industry Growth | 0.7% |
| Revenue growth rate | -19.0% |
| Return on equity | -167.9% |
| Net Margin | -1,111.5% |
| Next Earnings Update | 22 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Prostatype Genomics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4 | -41 | 18 | 3 |
| 30 Sep 23 | 2 | -38 | 16 | 3 |
| 30 Jun 23 | 1 | -34 | 13 | 4 |
| 31 Mar 23 | 1 | -31 | 12 | 3 |
| 31 Dec 22 | 1 | -29 | 10 | 4 |
| 30 Sep 22 | 1 | -27 | 10 | 3 |
| 30 Jun 22 | 1 | -23 | 9 | 2 |
| 31 Mar 22 | 2 | -18 | 8 | 2 |
| 31 Dec 21 | 3 | -16 | 8 | 1 |
| 30 Sep 21 | 3 | -14 | 7 | 1 |
| 30 Jun 21 | 3 | -14 | 7 | 0 |
| 31 Mar 21 | 3 | -15 | 7 | 1 |
| 31 Dec 20 | 3 | -14 | 6 | 2 |
| 30 Jun 20 | 3 | -9 | 5 | 2 |
| 30 Jun 19 | 3 | -9 | 5 | 1 |
| 30 Jun 18 | 5 | -9 | 5 | 3 |
| 30 Jun 17 | 5 | -5 | 2 | 2 |
| 30 Jun 16 | 0 | -11 | 3 | 2 |
Quality Earnings: PROGEN is currently unprofitable.
Growing Profit Margin: PROGEN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PROGEN is unprofitable, and losses have increased over the past 5 years at a rate of 35.7% per year.
Accelerating Growth: Unable to compare PROGEN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PROGEN is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-1.3%).
Return on Equity
High ROE: PROGEN has a negative Return on Equity (-167.93%), as it is currently unprofitable.